Heron Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Revenue	144.29	127.04	107.67	86.35	88.64	Upgrade
Revenue Growth (YoY)	13.57%	17.99%	24.70%	-2.59%	-39.28%	Upgrade
Cost of Revenue	55.33	100.24	133.38	175.64	209.52	Upgrade
Gross Profit	88.95	26.81	-25.71	-89.3	-120.88	Upgrade
Selling, General & Admin	100.48	119.82	143.55	127.13	101.68	Upgrade
Operating Expenses	100.48	119.82	143.55	127.13	101.68	Upgrade
Operating Income	-11.53	-93.02	-169.26	-216.43	-222.56	Upgrade
Interest Expense	-6.03	-3.87	-2.47	-2.41	-1.9	Upgrade
Interest & Investment Income	3.55	3.36	1.64	0.43	3.63	Upgrade
Other Non Operating Income (Expenses)	4.83	1.18	-6.32	-0.4	-	Upgrade
EBT Excluding Unusual Items	-9.18	-92.34	-176.42	-218.81	-220.83	Upgrade
Merger & Restructuring Charges	-	-4.2	-5.4	-1.4	-5.6	Upgrade
Gain (Loss) on Sale of Investments	0.01	-0	-	-	-	Upgrade
Asset Writedown	-4.41	-0.62	-0.21	-0.48	-0.85	Upgrade
Other Unusual Items	-	-13.4	-	-	-	Upgrade
Pretax Income	-13.58	-110.56	-182.02	-220.68	-227.28	Upgrade
Net Income	-13.58	-110.56	-182.02	-220.68	-227.28	Upgrade
Net Income to Common	-13.58	-110.56	-182.02	-220.68	-227.28	Upgrade
Shares Outstanding (Basic)	152	138	109	98	91	Upgrade
Shares Outstanding (Diluted)	152	138	109	98	91	Upgrade
Shares Change (YoY)	10.36%	26.87%	10.57%	8.48%	11.00%	Upgrade
EPS (Basic)	-0.09	-0.80	-1.67	-2.24	-2.50	Upgrade
EPS (Diluted)	-0.09	-0.80	-1.67	-2.24	-2.50	Upgrade
Free Cash Flow	-24.24	-60.33	-148.74	-206.38	-191.63	Upgrade
Free Cash Flow Per Share	-0.16	-0.44	-1.37	-2.10	-2.11	Upgrade
Gross Margin	61.65%	21.10%	-23.87%	-103.42%	-136.38%	Upgrade
Operating Margin	-7.99%	-73.22%	-157.20%	-250.65%	-251.09%	Upgrade
Profit Margin	-9.41%	-87.02%	-169.05%	-255.58%	-256.41%	Upgrade
Free Cash Flow Margin	-16.80%	-47.49%	-138.14%	-239.01%	-216.20%	Upgrade
EBITDA	-9.04	-90.12	-166.37	-213.41	-219.72	Upgrade
EBITDA Margin	-6.26%	-70.93%	-154.52%	-247.15%	-247.88%	Upgrade
D&A For EBITDA	2.49	2.9	2.89	3.02	2.85	Upgrade
EBIT	-11.53	-93.02	-169.26	-216.43	-222.56	Upgrade
EBIT Margin	-7.99%	-73.22%	-157.20%	-250.65%	-251.09%	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q